ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977

Chart of Core Grants

October 18, 1991

Trials Approved by NCI CTEP For The Month of February

February 24, 2012